Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Dig Dis Sci ; 58(3): 678-85, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23053894

RESUMEN

BACKGROUND: Growth of the small intestine in the infant rat is promoted by crypt fission and later by increased crypt cell proliferation. Notch signaling could promote crypt fission. Hes-1 is a Notch target gene. AIM: We assessed the effect of Notch signaling on intestinal crypt fission and on growth of the intestine in the infant rat. METHODS: Hes-1 expression was determined in the small intestine of litters of Hooded Wistar rats aged between 3 and 72 days. Hes-1 RNA expression was measured by quantitative RT-PCR. Four groups of rats (n = 8 or 9) were injected daily, ip, either with vehicle or with the Notch inhibitor DAPT at doses of 3, 10, and 30 mg/kg, from days 9 to 13 of life, and killed on day 14. A microdissection technique was used to measure crypt fission, mitotic count, and apoptotic count. Data were analyzed by ANOVA and by use of Dunnett's F test. RESULTS: Hes-1 expression and crypt fission peaked on day 14. DAPT reduced Hes-1 immunostaining in proportion to dose. DAPT reduced villous area to 72 % (p < 0.01), 53 % (p < 0.001), and 38 % (p < 0.001) of control values for 3, 10 and 30 mg/kg doses, respectively, and reduced crypt fission to 53 % (p < 0.001) and 38 % (p < 0.001) of control values, respectively, for 10 and 30 mg/kg doses. Crypt mitotic count was not affected by any DAPT dose. DAPT at 10 and 30 mg/kg significantly increased apoptosis in crypts, by 6.5 and 4.8-fold, respectively. CONCLUSIONS: We conclude that Notch signaling promotes crypt fission and growth of the intestine by maintaining low apoptosis of crypt cells.


Asunto(s)
Intestino Delgado/crecimiento & desarrollo , Intestino Delgado/metabolismo , Receptores Notch/metabolismo , Transducción de Señal/fisiología , Envejecimiento , Animales , Apoptosis , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/metabolismo , ADN Complementario/genética , ADN Complementario/metabolismo , Dipéptidos/farmacología , Femenino , Regulación del Desarrollo de la Expresión Génica/fisiología , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Masculino , ARN/genética , ARN/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores Notch/genética , Factor de Transcripción HES-1
2.
J Pediatr Gastroenterol Nutr ; 55(1): 26-31, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22193181

RESUMEN

OBJECTIVES: Intestinal crypt fission peaks during infancy. In human and experimental familial polyposis coli, increased crypt fission is due to activation of Wnt/ß-catenin signalling, but the molecular basis of crypt fission during intestinal growth has not been examined. The aim of this project was to investigate whether crypt fission and intestinal growth are affected by experimental blockade of the Wnt/ß-catenin signalling pathway. METHODS: Hooded Wistar rats were given either the Wnt inhibitor, dickkopf (30 and 100 ng), daily or vehicle control intraperitoneally from days 11 to 15 and were killed at day 16. Intestinal morphometry was used to measure villous area, crypt area, percentage of crypt fission, and crypt mitotic count. Intestinal stem cells were assessed by expression of real time-polymerase chain reaction for Lgr5 (a stem cell marker), and the number of ß-catenin-expressing crypts by immunostaining was determined after 100-ng dickkopf treatment. RESULTS: Dickkopf at 30 and 100 ng/day reduced villous area to 71% (P = 0.013) and 29% (P < 0.0001), crypt area to 42% (P = 0.0026) and 30% (P = 0.0067), and crypt fission to 51% (P = 0.006) and 29% (P < 0.0001), respectively, of control values. Mitotic count per crypt did not change. Lgr5 RNA expression and the number of ß-catenin-expressing crypts decreased in dickkopf-treated animals. CONCLUSIONS: We conclude that intestinal crypt fission during infancy is mediated by Wnt signalling. It is possible that local treatment with Wnt agonists could be used to increase intestinal growth.


Asunto(s)
Péptidos y Proteínas de Señalización Intercelular/farmacología , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Vía de Señalización Wnt/efectos de los fármacos , beta Catenina/metabolismo , Animales , Intestinos/patología , Índice Mitótico , Complejo Represivo Polycomb 1/efectos de los fármacos , Complejo Represivo Polycomb 1/metabolismo , ARN/metabolismo , Ratas , Ratas Wistar , Receptores Acoplados a Proteínas G/efectos de los fármacos , Receptores Acoplados a Proteínas G/metabolismo , Células Madre/metabolismo , beta Catenina/efectos de los fármacos
3.
Biochim Biophys Acta ; 1793(7): 1228-35, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19406171

RESUMEN

The epithelial tight junction forms a barrier to paracellular solute movement. In this study we show that the heterotrimeric G-protein Galpha13 regulates the epithelial tight junction barrier. We generated MDCKII kidney epithelial cell lines in which the expression of an active Galpha13 mutant (Galpha13Q226L) could be induced. We demonstrated that Galpha13Q226L expression increased paracellular permeability and caused the disruption and redistribution of proteins comprising the tight junction and the adherens junction away from sites of cell contact and the appearance of basal stress fibers. The effects on the junctional proteins and the actin cytoskeleton were abrogated by the Rho kinase inhibitor Y27632 but not by the Src kinase inhibitor PP2. The Galpha13 mediated increase in permeability was also Src kinase independent but was partly dependent on Rho kinase signalling. Our data establish a link between Galpha13, Rho kinase signaling and epithelial barrier function and not only demonstrate that Galpha13 regulates epithelial apical junction properties but that it does so via signaling pathways that are distinct from the closely related protein Galpha12.


Asunto(s)
Uniones Adherentes/fisiología , Epitelio/metabolismo , Subunidades alfa de la Proteína de Unión al GTP G12-G13/fisiología , Uniones Estrechas/fisiología , Quinasas Asociadas a rho/metabolismo , Familia-src Quinasas/metabolismo , Amidas/farmacología , Animales , Permeabilidad de la Membrana Celular/fisiología , Perros , Inhibidores Enzimáticos/farmacología , Técnicas para Inmunoenzimas , Riñón/citología , Riñón/metabolismo , Mutación/genética , Piridinas/farmacología , Quinasas Asociadas a rho/antagonistas & inhibidores
4.
Methods Mol Biol ; 763: 115-37, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21874448

RESUMEN

The integrity, or barrier function, of the intestinal epithelium is of paramount importance in -maintaining good health. This is largely imparted by a single layer of epithelial cells linked by the transmembrane tight junction protein complex near their apical surface. Disruption of epithelial permeability via the tight junctions can contribute to disease progression. The cytokine IFNγ is involved in many inflammatory processes and has been shown to dramatically increase permeability via changes at the tight junction in experimental models. One of its key effectors is the transcription factor, -IRF-1. In our studies of the role of IRF-1 in barrier function using the human T84 intestinal epithelial cell monolayer model, we have found that induction of IRF-1 alone is insufficient to change permeability and that if IRF-1 is involved in mediating the permeability effects of IFNγ, then other factors must also be required.


Asunto(s)
Células Epiteliales/metabolismo , Factor 1 Regulador del Interferón/metabolismo , Interferón gamma/metabolismo , Mucosa Intestinal/metabolismo , Proteínas de la Membrana/metabolismo , Uniones Estrechas/metabolismo , Western Blotting , Línea Celular , Dextranos/análisis , Cámaras de Difusión de Cultivos , Electroforesis en Gel de Poliacrilamida , Células Epiteliales/citología , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/análisis , Técnica del Anticuerpo Fluorescente , Humanos , Inmunohistoquímica , Inflamación/inmunología , Inflamación/metabolismo , Factor 1 Regulador del Interferón/genética , Factor 1 Regulador del Interferón/inmunología , Interferón gamma/genética , Interferón gamma/inmunología , Mucosa Intestinal/citología , Intestinos/citología , Proteínas de la Membrana/genética , Ocludina , Permeabilidad , Plásmidos , Uniones Estrechas/genética , Uniones Estrechas/inmunología , Transfección
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda